secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001437749-24-020967
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
LLM model:  deepseek-v4-flash:cloud@v2

Eton replaces auditor KMJ Corbin with Crowe after KMJ partners join Crowe; no disagreements
--------------------------------------------------------------------------------

- KMJ Corbin resigned as independent auditor effective June 14, 2024; Crowe appointed same day with Audit Committee approval.
- Partners and professional staff of KMJ joined Crowe, triggering the resignation and appointment.
- KMJ's reports for fiscal 2022 and 2023 contained no adverse opinion or modification.
- No disagreements or reportable events between Eton and KMJ during those periods or the subsequent interim period.
- KMJ provided a letter agreeing with the company's statements, filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774924020967/0001437749-24-020967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774924020967/eton20240510_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-020967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer